This announcement is a separate document:
*ST景峰：湖南景峰医药股份有限公司2016年面向合格投资者公开发行公司债券(第一期)受托管理事务报告（2023年度）
Hunan Jingfeng Pharmaceutical: Hunan Jingfeng Pharmaceutical Co., Ltd.'s entrusted management report on the public issuance of corporate bonds (first phase) for qualified investors in 2016 (2023).
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.